Baylor University Medical Center Proceedings April 2014, Volume 27, Number 2 | Page 5

Validation of Rules of TwoTM as a paradigm for assessing asthma control Mark Millard, MD, Mary Hart, MS, RRT, AE-C, and Sunni Barnes, PhD Assessing asthma control at each patient encounter is an essential task to determine pharmacologic requirements. Rules of Two (Ro2) was created from the original 1991 National Asthma Education Program guidelines to determine the need for controller therapy. This study determined the degree of agreement between Ro2 and the Expert Panel Report (EPR-3) definition of “in control” asthma and compared that value with the Asthma Control Test (ACT) in a group of asthmatics for the purpose of validating this tool. Patients with documented asthma were randomized to complete Ro2 or ACT prior to being assessed for asthma control by certified asthma educators using an EPR-3 template. Assessments occurred in either a specialty asthma clinic or at a local health fair. Patients were also queried for their personal assessment of asthma control. The primary statistical methodology employed was the degree of agreement (kappa) between each survey tool and the EPR-3 template. Of 150 patients, 72% did not have their asthma in control, based on the EPR-3 template. Ro2 identified 58% of patients not in control of their asthma, whereas ACT identified 36%, with kappa scores of 0.41 for Ro2 and 0.37 for ACT compared with the EPR-3 template. These were not significantly different. Of the 150 patients, 75% considered their asthma in control based on self-assessments, with a kappa of 0.23. In 14 of 73 ACT questionnaires, scores were not added or were misadded. Eliminating evaluation of static lung function significantly improved both kappa scores of Ro2 and ACT. In conclusion, Ro2 identifies patients with uncontrolled asthma as well as ACT and may be useful to the primary assessing clinician in determining asthma control. he assessment of asthma control drives therapeutic decisions in patients with asthma, as articulated in the 2007 edition of the National Asthma Education and Prevention Program (NAEPP) (1), also referred to as the Expert Panel Report (EPR-3). That assessment reflects the contributions of two related domains, impairment and risk, and consists of patient-reported symptoms and symptom frequency, documentation of health care encounters, medication use, and objective measurement of lung function. The decision to step up, step down, or maintain any specific therapy rests upon the determination of asthma control. Rules of TwoTM (Ro2) was created in 1992 as a tool to signal the need for controller therapy according to the first National T Proc (Bayl Univ Med Cent) 2014;27(2):79–82 Asthma Education Program (NAEP) guidelines published in 1991. At that time, the use of controller therapy for patients with persistent asthma had not been generally accepted within the primary care community, and there was a need to develop an easily remembered synopsis of the NAEP criteria for mild persistent asthma, which was the point at which antiinflammatory therapy for asthma was first recommended. While abstracts demonstrating the impact of Ro2 educational efforts we